← Back

$ Value

$0

Shares

609

Price

$0

Filed

Oct 3

Insider

Name

Renaudin George II

Title

President, Insurance

CIK

0001964078

Roles

Officer

Transaction Details

Transaction Date

2025-10-01

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,311

Footnotes

Shares held for the benefit of reporting person as of September 30, 2025 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). | Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. | Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. | Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). | Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025. | Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. | Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | Phantom Stock Units held for the benefit of reporting person as of September 30, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. | Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return.

Filing Info

Accession No.

0001964078-25-000003

Form Type

4

Issuer CIK

0000049071

Renaudin George II's History

Date Ticker Type Value
2026-03-31 HUM J $4K
2026-02-24 HUM M $0
2026-02-24 HUM F $74K
2025-12-15 HUM M $0
2025-12-15 HUM F $224K
2025-12-15 HUM M $0
2025-12-15 HUM F $38K
2025-12-15 HUM M $0
2025-10-01 HUM M $0
2025-10-01 HUM F $61K

Other Insiders at HUM (90d)

Insider Bought Sold Last
Shetty Sanjay K
President, CenterWell
$150K 2026-04-01
HILZINGER KURT J 2026-03-31
Mellet Celeste
Chief Financial Officer
2026-02-13
Ventura Joseph C
Chief Legal Officer
2026-02-24
Felter John-Paul W.
SVP, Chief Accting Off & Cont.
2026-02-24
Renaudin George II
President, Insurance
2026-03-31
Dintenfass David
President, Enterprise Growth
2026-02-21
Mehta Japan
Chief Information Officer
2026-02-13
Martin Aaron
President, Medicare Advantage
2026-02-12